Your browser doesn't support javascript.
loading
[Favourable outcome after treatment with rituximab in a case of seronegative non-paraneoplastic Lambert-Eaton myasthenic syndrome]. / Efficacité du rituximab dans un cas de syndrome de Lambert-Eaton non paranéoplasique séronégatif.
Boutin, E; Rey, C; Romeu, M; Pouget, J; Franques, J.
Affiliation
  • Boutin E; Centre de référence des maladies neuromusculaires et de la SLA, centre hospitalier universitaire de La Timone, 264 rue Saint-Pierre, Marseille cedex 05, France. emmanuelle.boutin@ap-hm.fr
Rev Med Interne ; 34(8): 493-6, 2013 Aug.
Article in Fr | MEDLINE | ID: mdl-23759215
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lambert-Eaton Myasthenic Syndrome / Antibodies, Monoclonal, Murine-Derived / Immunosuppressive Agents Limits: Adult / Humans / Male Language: Fr Journal: Rev Med Interne Year: 2013 Document type: Article Affiliation country: France Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lambert-Eaton Myasthenic Syndrome / Antibodies, Monoclonal, Murine-Derived / Immunosuppressive Agents Limits: Adult / Humans / Male Language: Fr Journal: Rev Med Interne Year: 2013 Document type: Article Affiliation country: France Country of publication: France